

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 5.73850330 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.51819859 |
| 3 | central nervous system myelination (GO:0022010) | 5.51819859 |
| 4 | ether lipid metabolic process (GO:0046485) | 4.83357244 |
| 5 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.75236718 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 4.28254805 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.28254805 |
| 8 | cholesterol biosynthetic process (GO:0006695) | 4.01876244 |
| 9 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.01875392 |
| 10 | axon ensheathment (GO:0008366) | 4.00692699 |
| 11 | ensheathment of neurons (GO:0007272) | 4.00692699 |
| 12 | myelination (GO:0042552) | 3.97055953 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 3.91697784 |
| 14 | ER overload response (GO:0006983) | 3.90025299 |
| 15 | negative regulation of neurotransmitter transport (GO:0051589) | 3.79315546 |
| 16 | synapsis (GO:0007129) | 3.78017656 |
| 17 | asymmetric protein localization (GO:0008105) | 3.66297625 |
| 18 | nucleotide transmembrane transport (GO:1901679) | 3.63984603 |
| 19 | ribosome assembly (GO:0042255) | 3.63049231 |
| 20 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 3.62896889 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 3.61799679 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.61799679 |
| 23 | branched-chain amino acid catabolic process (GO:0009083) | 3.61363244 |
| 24 | apical protein localization (GO:0045176) | 3.60405356 |
| 25 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.59694588 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.57465361 |
| 27 | glycerophospholipid catabolic process (GO:0046475) | 3.51775185 |
| 28 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.41696093 |
| 29 | eye photoreceptor cell differentiation (GO:0001754) | 3.40252904 |
| 30 | photoreceptor cell differentiation (GO:0046530) | 3.40252904 |
| 31 | sterol biosynthetic process (GO:0016126) | 3.38682851 |
| 32 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.33977223 |
| 33 | glycerol ether metabolic process (GO:0006662) | 3.28304865 |
| 34 | carnitine metabolic process (GO:0009437) | 3.25279058 |
| 35 | signal peptide processing (GO:0006465) | 3.24693051 |
| 36 | polyol biosynthetic process (GO:0046173) | 3.24551402 |
| 37 | iron ion import (GO:0097286) | 3.18956403 |
| 38 | platelet dense granule organization (GO:0060155) | 3.18667337 |
| 39 | Golgi transport vesicle coating (GO:0048200) | 3.18243940 |
| 40 | COPI coating of Golgi vesicle (GO:0048205) | 3.18243940 |
| 41 | regulation of meiosis I (GO:0060631) | 3.15361913 |
| 42 | magnesium ion transport (GO:0015693) | 3.12925904 |
| 43 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.12772746 |
| 44 | C4-dicarboxylate transport (GO:0015740) | 3.12076900 |
| 45 | amyloid precursor protein metabolic process (GO:0042982) | 3.11714249 |
| 46 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.11324174 |
| 47 | oligosaccharide catabolic process (GO:0009313) | 3.09502944 |
| 48 | branched-chain amino acid metabolic process (GO:0009081) | 3.08778295 |
| 49 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.04157430 |
| 50 | resolution of meiotic recombination intermediates (GO:0000712) | 3.03673751 |
| 51 | very long-chain fatty acid metabolic process (GO:0000038) | 3.03084139 |
| 52 | presynaptic membrane assembly (GO:0097105) | 3.03038079 |
| 53 | response to lipoprotein particle (GO:0055094) | 3.02817737 |
| 54 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.99256792 |
| 55 | response to hepatocyte growth factor (GO:0035728) | 2.99256792 |
| 56 | endocrine pancreas development (GO:0031018) | 2.98855183 |
| 57 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.98750120 |
| 58 | fatty acid beta-oxidation (GO:0006635) | 2.96531543 |
| 59 | acyl-CoA biosynthetic process (GO:0071616) | 2.93455015 |
| 60 | thioester biosynthetic process (GO:0035384) | 2.93455015 |
| 61 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.92010554 |
| 62 | myelin maintenance (GO:0043217) | 2.90938461 |
| 63 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.90767894 |
| 64 | ether metabolic process (GO:0018904) | 2.90579676 |
| 65 | protein palmitoylation (GO:0018345) | 2.90275391 |
| 66 | aromatic amino acid family catabolic process (GO:0009074) | 2.89011808 |
| 67 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.88822978 |
| 68 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.86024955 |
| 69 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.86024955 |
| 70 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.86024955 |
| 71 | presynaptic membrane organization (GO:0097090) | 2.85273441 |
| 72 | peptide catabolic process (GO:0043171) | 2.83446339 |
| 73 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.80625632 |
| 74 | response to pheromone (GO:0019236) | 2.80608606 |
| 75 | short-chain fatty acid metabolic process (GO:0046459) | 2.79340662 |
| 76 | detection of molecule of bacterial origin (GO:0032490) | 2.79181150 |
| 77 | amyloid precursor protein catabolic process (GO:0042987) | 2.76376108 |
| 78 | valine metabolic process (GO:0006573) | 2.75276687 |
| 79 | phospholipid homeostasis (GO:0055091) | 2.75154500 |
| 80 | peptide hormone processing (GO:0016486) | 2.74886106 |
| 81 | response to dietary excess (GO:0002021) | 2.73334879 |
| 82 | negative regulation of complement activation (GO:0045916) | 2.71392175 |
| 83 | mitotic sister chromatid cohesion (GO:0007064) | 2.71033669 |
| 84 | lipid oxidation (GO:0034440) | 2.70641483 |
| 85 | oligodendrocyte differentiation (GO:0048709) | 2.69639372 |
| 86 | isoprenoid biosynthetic process (GO:0008299) | 2.68688908 |
| 87 | fatty acid oxidation (GO:0019395) | 2.67359945 |
| 88 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.64303355 |
| 89 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.64221653 |
| 90 | nucleotide transport (GO:0006862) | 2.64201022 |
| 91 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.62470998 |
| 92 | sphingomyelin metabolic process (GO:0006684) | 2.62036921 |
| 93 | response to hydroperoxide (GO:0033194) | 2.61485316 |
| 94 | response to redox state (GO:0051775) | 2.61442799 |
| 95 | regulation of collateral sprouting (GO:0048670) | 2.61291087 |
| 96 | sphingosine metabolic process (GO:0006670) | 2.61106806 |
| 97 | phospholipid scrambling (GO:0017121) | 2.60490883 |
| 98 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.59512399 |
| 99 | negative regulation of JUN kinase activity (GO:0043508) | 2.58570490 |
| 100 | response to methylmercury (GO:0051597) | 2.57818294 |
| 101 | sequestering of metal ion (GO:0051238) | 2.57113085 |
| 102 | pH reduction (GO:0045851) | 2.57063932 |
| 103 | creatine metabolic process (GO:0006600) | 2.55740931 |
| 104 | intracellular pH reduction (GO:0051452) | 2.55240596 |
| 105 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.54973104 |
| 106 | tyrosine metabolic process (GO:0006570) | 2.54769227 |
| 107 | proteasome assembly (GO:0043248) | 2.54141507 |
| 108 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.51076555 |
| 109 | fatty acid catabolic process (GO:0009062) | 2.50745447 |
| 110 | substantia nigra development (GO:0021762) | 2.50611444 |
| 111 | regulation of sulfur metabolic process (GO:0042762) | 2.50300088 |
| 112 | cellular response to gamma radiation (GO:0071480) | 2.48725959 |
| 113 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.48680209 |
| 114 | histamine secretion (GO:0001821) | 2.46606676 |
| 115 | COPII vesicle coating (GO:0048208) | 2.45269918 |
| 116 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.45233588 |
| 117 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.45233588 |
| 118 | tricarboxylic acid cycle (GO:0006099) | 2.45157987 |
| 119 | protein targeting to vacuole (GO:0006623) | 2.44718874 |
| 120 | protein targeting to lysosome (GO:0006622) | 2.44718874 |
| 121 | establishment of protein localization to vacuole (GO:0072666) | 2.44718874 |
| 122 | negative regulation of protein activation cascade (GO:2000258) | 2.44681109 |
| 123 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.44217752 |
| 124 | metaphase plate congression (GO:0051310) | 2.43809497 |
| 125 | amino-acid betaine metabolic process (GO:0006577) | 2.43601438 |
| 126 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.42739186 |
| 127 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.42579331 |
| 128 | regulation of protein glycosylation (GO:0060049) | 2.42239828 |
| 129 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.41928903 |
| 130 | macroautophagy (GO:0016236) | 2.41084941 |
| 131 | virion attachment to host cell (GO:0019062) | 2.40488195 |
| 132 | adhesion of symbiont to host cell (GO:0044650) | 2.40488195 |
| 133 | establishment of chromosome localization (GO:0051303) | 2.39224816 |
| 134 | Golgi to plasma membrane protein transport (GO:0043001) | 2.37894025 |
| 135 | plasma lipoprotein particle assembly (GO:0034377) | 2.37724404 |
| 136 | peroxisome fission (GO:0016559) | 2.35612712 |
| 137 | regulation of lipoprotein metabolic process (GO:0050746) | 2.33939733 |
| 138 | neuronal ion channel clustering (GO:0045161) | 2.33836817 |
| 139 | retinal metabolic process (GO:0042574) | 2.33712259 |
| 140 | modulation by symbiont of host defense response (GO:0052031) | 2.33590734 |
| 141 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.33590734 |
| 142 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.33590734 |
| 143 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.33590734 |
| 144 | modulation by symbiont of host immune response (GO:0052553) | 2.33590734 |
| 145 | positive regulation by symbiont of host defense response (GO:0052509) | 2.33590734 |
| 146 | glycoside metabolic process (GO:0016137) | 2.31232453 |
| 147 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.29779206 |
| 148 | negative regulation of digestive system process (GO:0060457) | 2.29445246 |
| 149 | aldehyde catabolic process (GO:0046185) | 2.29355864 |
| 150 | protein maturation by protein folding (GO:0022417) | 2.28999278 |
| 151 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.28966995 |
| 152 | response to peptidoglycan (GO:0032494) | 2.28426404 |
| 153 | prostate gland growth (GO:0060736) | 2.27891020 |
| 154 | membrane protein ectodomain proteolysis (GO:0006509) | 2.27318451 |
| 155 | vitamin biosynthetic process (GO:0009110) | 2.26293121 |
| 156 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.26117903 |
| 157 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.24938019 |
| 158 | glucosamine-containing compound catabolic process (GO:1901072) | 2.24598182 |
| 159 | piRNA metabolic process (GO:0034587) | 2.24485065 |
| 160 | glycosylceramide metabolic process (GO:0006677) | 2.24437746 |
| 161 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.23804480 |
| 162 | positive regulation of muscle hypertrophy (GO:0014742) | 2.23804480 |
| 163 | histone mRNA catabolic process (GO:0071044) | 2.23220342 |
| 164 | non-recombinational repair (GO:0000726) | 2.23081586 |
| 165 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.23081586 |
| 166 | regulation of cholesterol esterification (GO:0010872) | 2.23014150 |
| 167 | alpha-linolenic acid metabolic process (GO:0036109) | 2.22856322 |
| 168 | response to nitrosative stress (GO:0051409) | 2.22479187 |
| 169 | vitamin D metabolic process (GO:0042359) | 2.21874083 |
| 170 | protein targeting to Golgi (GO:0000042) | 2.21394378 |
| 171 | mitochondrial DNA replication (GO:0006264) | 2.21046509 |
| 172 | regulation of cofactor metabolic process (GO:0051193) | 2.20490245 |
| 173 | establishment of mitochondrion localization (GO:0051654) | 2.20371432 |
| 174 | ear development (GO:0043583) | 2.17854679 |
| 175 | negative regulation of protein localization to cell surface (GO:2000009) | 2.17618152 |
| 176 | negative regulation of axonogenesis (GO:0050771) | 2.17493603 |
| 177 | mammary gland alveolus development (GO:0060749) | 2.17469141 |
| 178 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.16212236 |
| 179 | import into cell (GO:0098657) | 2.14350270 |
| 180 | nerve growth factor signaling pathway (GO:0038180) | 2.13014913 |
| 181 | zinc ion transmembrane transport (GO:0071577) | 2.12903854 |
| 182 | myelin assembly (GO:0032288) | 2.11807738 |
| 183 | acyl-CoA metabolic process (GO:0006637) | 2.10171908 |
| 184 | thioester metabolic process (GO:0035383) | 2.10171908 |
| 185 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.09946761 |
| 186 | peroxisome organization (GO:0007031) | 2.09321882 |
| 187 | Golgi to plasma membrane transport (GO:0006893) | 2.09204851 |
| 188 | Golgi to endosome transport (GO:0006895) | 2.09195166 |
| 189 | peptidyl-cysteine modification (GO:0018198) | 2.07714558 |
| 190 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.07593930 |
| 191 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.06930434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.19197995 |
| 2 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.93043085 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.77884223 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.67350972 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.63050165 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.51059455 |
| 7 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.43593344 |
| 8 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.41668168 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.36480318 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.23571786 |
| 11 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.18921351 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.17110888 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.09645131 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.07120891 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00989813 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.00650447 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.00221984 |
| 18 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.99100414 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 1.86303953 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.86005159 |
| 21 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.85424195 |
| 22 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.85424195 |
| 23 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.85241208 |
| 24 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.83356525 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.81190578 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80293070 |
| 27 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.77368558 |
| 28 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.72452508 |
| 29 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.70593262 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.65492223 |
| 31 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64803293 |
| 32 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.62223874 |
| 33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.61667482 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57912874 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55854275 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55733382 |
| 37 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.55439029 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54558481 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53156899 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52561882 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52550139 |
| 42 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.52389810 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51673529 |
| 44 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.51069662 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50971416 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50586527 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49983274 |
| 48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49246912 |
| 49 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47311968 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46563479 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.46248906 |
| 52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.45488059 |
| 53 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.43379613 |
| 54 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.42810654 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42660725 |
| 56 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.42582777 |
| 57 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.42472487 |
| 58 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.41975994 |
| 59 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.41700670 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40792487 |
| 61 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.40093510 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38328624 |
| 63 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38318191 |
| 64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38210371 |
| 65 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.38106277 |
| 66 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.37527873 |
| 67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33558589 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31966774 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31119937 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30974724 |
| 71 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30176485 |
| 72 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29997716 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.29459681 |
| 74 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27437910 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27344916 |
| 76 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27211089 |
| 77 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27141879 |
| 78 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26654159 |
| 79 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.26188628 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24953771 |
| 81 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.24063449 |
| 82 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.23552810 |
| 83 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23061268 |
| 84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22766232 |
| 85 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.22408279 |
| 86 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.21674182 |
| 87 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20785845 |
| 88 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20749335 |
| 89 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.20505373 |
| 90 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.20424330 |
| 91 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19871669 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19089815 |
| 93 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18221795 |
| 94 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17517070 |
| 95 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15347413 |
| 96 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15336932 |
| 97 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.15275904 |
| 98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.15073187 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14221403 |
| 100 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.11920802 |
| 101 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.11498050 |
| 102 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10817120 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10248731 |
| 104 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10182191 |
| 105 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.09562012 |
| 106 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09345150 |
| 107 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.08982202 |
| 108 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08714530 |
| 109 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.08620966 |
| 110 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07629078 |
| 111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07490923 |
| 112 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06650993 |
| 113 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.06163799 |
| 114 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04944764 |
| 115 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.04929178 |
| 116 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04817902 |
| 117 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04036673 |
| 118 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03953526 |
| 119 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.03831869 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03735180 |
| 121 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03615416 |
| 122 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.03251141 |
| 123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03194994 |
| 124 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.03168161 |
| 125 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03161270 |
| 126 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03100334 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02847214 |
| 128 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02711000 |
| 129 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02337763 |
| 130 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02287229 |
| 131 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02146051 |
| 132 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01426301 |
| 133 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01118081 |
| 134 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99927083 |
| 135 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99642204 |
| 136 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.98948258 |
| 137 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98937234 |
| 138 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98453554 |
| 139 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98449178 |
| 140 | JUN_21703547_ChIP-Seq_K562_Human | 0.98309229 |
| 141 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96666449 |
| 142 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96550475 |
| 143 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96470922 |
| 144 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96397662 |
| 145 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96013541 |
| 146 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95953211 |
| 147 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95953211 |
| 148 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95772328 |
| 149 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95107028 |
| 150 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.94954170 |
| 151 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.94861808 |
| 152 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94128194 |
| 153 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93879377 |
| 154 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93757349 |
| 155 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.93686505 |
| 156 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93569242 |
| 157 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92867449 |
| 158 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92856016 |
| 159 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92803962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 3.69515434 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.52458921 |
| 3 | MP0003195_calcinosis | 3.48992583 |
| 4 | MP0003656_abnormal_erythrocyte_physiolo | 3.19509115 |
| 5 | MP0004270_analgesia | 2.95668405 |
| 6 | MP0000013_abnormal_adipose_tissue | 2.94831147 |
| 7 | MP0004043_abnormal_pH_regulation | 2.89948988 |
| 8 | MP0005365_abnormal_bile_salt | 2.82928541 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.68069579 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.57712957 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.52049603 |
| 12 | MP0010386_abnormal_urinary_bladder | 2.45087924 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.40351406 |
| 14 | MP0005174_abnormal_tail_pigmentation | 2.38024476 |
| 15 | MP0008057_abnormal_DNA_replication | 2.37592014 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.31014126 |
| 17 | MP0003880_abnormal_central_pattern | 2.28360713 |
| 18 | MP0006054_spinal_hemorrhage | 2.25225406 |
| 19 | MP0003690_abnormal_glial_cell | 2.24321194 |
| 20 | MP0003329_amyloid_beta_deposits | 2.24057578 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 2.21015332 |
| 22 | MP0005360_urolithiasis | 2.20450591 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 2.07609029 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 2.05556956 |
| 25 | MP0005379_endocrine/exocrine_gland_phen | 2.02395542 |
| 26 | MP0001661_extended_life_span | 1.99484295 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.93250435 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.89738485 |
| 29 | MP0001529_abnormal_vocalization | 1.76621280 |
| 30 | MP0002272_abnormal_nervous_system | 1.75245002 |
| 31 | MP0001905_abnormal_dopamine_level | 1.72641546 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.71992461 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.69905623 |
| 34 | MP0000604_amyloidosis | 1.69435467 |
| 35 | MP0003186_abnormal_redox_activity | 1.69134040 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.67047016 |
| 37 | MP0008004_abnormal_stomach_pH | 1.66100706 |
| 38 | MP0003724_increased_susceptibility_to | 1.64178713 |
| 39 | MP0009697_abnormal_copulation | 1.58579353 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.58550327 |
| 41 | MP0004742_abnormal_vestibular_system | 1.58466065 |
| 42 | MP0002693_abnormal_pancreas_physiology | 1.55562107 |
| 43 | MP0000427_abnormal_hair_cycle | 1.55180851 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.55014803 |
| 45 | MP0009840_abnormal_foam_cell | 1.54700085 |
| 46 | MP0003634_abnormal_glial_cell | 1.54012668 |
| 47 | MP0008058_abnormal_DNA_repair | 1.53414772 |
| 48 | MP0003632_abnormal_nervous_system | 1.53017910 |
| 49 | MP0002734_abnormal_mechanical_nocicepti | 1.48694014 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.48651453 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.48562056 |
| 52 | MP0003828_pulmonary_edema | 1.47913702 |
| 53 | MP0005451_abnormal_body_composition | 1.47556730 |
| 54 | MP0002064_seizures | 1.45650208 |
| 55 | MP0003252_abnormal_bile_duct | 1.45404972 |
| 56 | MP0002229_neurodegeneration | 1.45327274 |
| 57 | MP0005332_abnormal_amino_acid | 1.42140822 |
| 58 | MP0004885_abnormal_endolymph | 1.41391314 |
| 59 | MP0001299_abnormal_eye_distance/ | 1.39923579 |
| 60 | MP0000778_abnormal_nervous_system | 1.39745309 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.38981316 |
| 62 | MP0001944_abnormal_pancreas_morphology | 1.37887434 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.37593925 |
| 64 | MP0000003_abnormal_adipose_tissue | 1.37224701 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.37027028 |
| 66 | MP0001486_abnormal_startle_reflex | 1.33523915 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.33096552 |
| 68 | MP0005310_abnormal_salivary_gland | 1.29995261 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 1.29458434 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.29288016 |
| 71 | MP0003635_abnormal_synaptic_transmissio | 1.26360373 |
| 72 | MP0004859_abnormal_synaptic_plasticity | 1.25727278 |
| 73 | MP0010307_abnormal_tumor_latency | 1.25438668 |
| 74 | MP0009745_abnormal_behavioral_response | 1.25318539 |
| 75 | MP0008877_abnormal_DNA_methylation | 1.25280477 |
| 76 | MP0002572_abnormal_emotion/affect_behav | 1.25012529 |
| 77 | MP0001764_abnormal_homeostasis | 1.24602665 |
| 78 | MP0003631_nervous_system_phenotype | 1.22005619 |
| 79 | MP0003868_abnormal_feces_composition | 1.21038281 |
| 80 | MP0001346_abnormal_lacrimal_gland | 1.20644501 |
| 81 | MP0005171_absent_coat_pigmentation | 1.19130168 |
| 82 | MP0003633_abnormal_nervous_system | 1.18711100 |
| 83 | MP0000358_abnormal_cell_content/ | 1.17284473 |
| 84 | MP0002118_abnormal_lipid_homeostasis | 1.17136568 |
| 85 | MP0004957_abnormal_blastocyst_morpholog | 1.16727195 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 1.16388133 |
| 87 | MP0001485_abnormal_pinna_reflex | 1.15219741 |
| 88 | MP0005248_abnormal_Harderian_gland | 1.14992092 |
| 89 | MP0002132_abnormal_respiratory_system | 1.13953074 |
| 90 | MP0002063_abnormal_learning/memory/cond | 1.12109096 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11250863 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 1.10702406 |
| 93 | MP0002733_abnormal_thermal_nociception | 1.09315109 |
| 94 | MP0005220_abnormal_exocrine_pancreas | 1.08418128 |
| 95 | MP0000383_abnormal_hair_follicle | 1.07977437 |
| 96 | MP0001666_abnormal_nutrient_absorption | 1.07073580 |
| 97 | MP0002095_abnormal_skin_pigmentation | 1.06716849 |
| 98 | MP0000955_abnormal_spinal_cord | 1.06588096 |
| 99 | MP0001835_abnormal_antigen_presentation | 1.06435015 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 1.04384152 |
| 101 | MP0009046_muscle_twitch | 1.02964649 |
| 102 | MP0000371_diluted_coat_color | 1.02594270 |
| 103 | MP0000462_abnormal_digestive_system | 1.02489973 |
| 104 | MP0000609_abnormal_liver_physiology | 1.01831996 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 1.01779874 |
| 106 | MP0001545_abnormal_hematopoietic_system | 1.01606120 |
| 107 | MP0005397_hematopoietic_system_phenotyp | 1.01606120 |
| 108 | MP0006082_CNS_inflammation | 1.01494954 |
| 109 | MP0003172_abnormal_lysosome_physiology | 1.00607811 |
| 110 | MP0001853_heart_inflammation | 1.00585056 |
| 111 | MP0002909_abnormal_adrenal_gland | 1.00572497 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 1.00508565 |
| 113 | MP0001970_abnormal_pain_threshold | 0.99819856 |
| 114 | MP0004924_abnormal_behavior | 0.99614380 |
| 115 | MP0005386_behavior/neurological_phenoty | 0.99614380 |
| 116 | MP0002090_abnormal_vision | 0.99549487 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.99155698 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 0.96511585 |
| 119 | MP0009785_altered_susceptibility_to | 0.96426403 |
| 120 | MP0005164_abnormal_response_to | 0.96255882 |
| 121 | MP0004019_abnormal_vitamin_homeostasis | 0.95999460 |
| 122 | MP0005535_abnormal_body_temperature | 0.95798407 |
| 123 | MP0005551_abnormal_eye_electrophysiolog | 0.95768864 |
| 124 | MP0005408_hypopigmentation | 0.95721576 |
| 125 | MP0004142_abnormal_muscle_tone | 0.95492876 |
| 126 | MP0004147_increased_porphyrin_level | 0.95046451 |
| 127 | MP0002419_abnormal_innate_immunity | 0.93559918 |
| 128 | MP0000343_altered_response_to | 0.92758781 |
| 129 | MP0003077_abnormal_cell_cycle | 0.92121615 |
| 130 | MP0000647_abnormal_sebaceous_gland | 0.91633530 |
| 131 | MP0004883_abnormal_blood_vessel | 0.91338179 |
| 132 | MP0003718_maternal_effect | 0.91188722 |
| 133 | MP0000538_abnormal_urinary_bladder | 0.90818261 |
| 134 | MP0009643_abnormal_urine_homeostasis | 0.90540364 |
| 135 | MP0000613_abnormal_salivary_gland | 0.90233703 |
| 136 | MP0005330_cardiomyopathy | 0.90088935 |
| 137 | MP0010678_abnormal_skin_adnexa | 0.89690282 |
| 138 | MP0003303_peritoneal_inflammation | 0.89673311 |
| 139 | MP0001502_abnormal_circadian_rhythm | 0.89555723 |
| 140 | MP0002166_altered_tumor_susceptibility | 0.89089917 |
| 141 | MP0002066_abnormal_motor_capabilities/c | 0.87307484 |
| 142 | MP0003941_abnormal_skin_development | 0.86538394 |
| 143 | MP0001845_abnormal_inflammatory_respons | 0.86303978 |
| 144 | MP0010329_abnormal_lipoprotein_level | 0.84829406 |
| 145 | MP0001177_atelectasis | 0.84712755 |
| 146 | MP0010094_abnormal_chromosome_stability | 0.84659753 |
| 147 | MP0006072_abnormal_retinal_apoptosis | 0.83212590 |
| 148 | MP0000516_abnormal_urinary_system | 0.83026632 |
| 149 | MP0005367_renal/urinary_system_phenotyp | 0.83026632 |
| 150 | MP0010155_abnormal_intestine_physiology | 0.81858236 |
| 151 | MP0008469_abnormal_protein_level | 0.81800367 |
| 152 | MP0008260_abnormal_autophagy | 0.81363475 |
| 153 | MP0006035_abnormal_mitochondrial_morpho | 0.81323891 |
| 154 | MP0002882_abnormal_neuron_morphology | 0.81038769 |
| 155 | MP0002067_abnormal_sensory_capabilities | 0.80980925 |
| 156 | MP0000639_abnormal_adrenal_gland | 0.80374580 |
| 157 | MP0008007_abnormal_cellular_replicative | 0.79356826 |
| 158 | MP0003011_delayed_dark_adaptation | 0.79142615 |
| 159 | MP0005275_abnormal_skin_tensile | 0.78716986 |
| 160 | MP0005376_homeostasis/metabolism_phenot | 0.78184278 |
| 161 | MP0000747_muscle_weakness | 0.77201813 |
| 162 | MP0002928_abnormal_bile_duct | 0.77056240 |
| 163 | MP0002163_abnormal_gland_morphology | 0.76902160 |
| 164 | MP0003448_altered_tumor_morphology | 0.74839904 |
| 165 | MP0005083_abnormal_biliary_tract | 0.73582893 |
| 166 | MP0003191_abnormal_cellular_cholesterol | 0.71032732 |
| 167 | MP0000230_abnormal_systemic_arterial | 0.69779269 |
| 168 | MP0006276_abnormal_autonomic_nervous | 0.68063142 |
| 169 | MP0001984_abnormal_olfaction | 0.67222254 |
| 170 | MP0002069_abnormal_eating/drinking_beha | 0.66948085 |
| 171 | MP0002938_white_spotting | 0.66840419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 4.64053047 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.24501720 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.24501720 |
| 4 | Hypoglycemic seizures (HP:0002173) | 4.06601253 |
| 5 | Sensory axonal neuropathy (HP:0003390) | 3.99340350 |
| 6 | Symptomatic seizures (HP:0011145) | 3.88780259 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.81248253 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 3.69801991 |
| 9 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.67654759 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 3.59845189 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 3.43838012 |
| 12 | Abnormality of the corticospinal tract (HP:0002492) | 3.04034859 |
| 13 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.03336195 |
| 14 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.02392187 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.02142832 |
| 16 | Metaphyseal dysplasia (HP:0100255) | 2.98977215 |
| 17 | Patchy hypopigmentation of hair (HP:0011365) | 2.97926442 |
| 18 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.97254367 |
| 19 | Recurrent abscess formation (HP:0002722) | 2.94286413 |
| 20 | Parakeratosis (HP:0001036) | 2.82116945 |
| 21 | Agnosia (HP:0010524) | 2.80101972 |
| 22 | Osteolytic defects of the hand bones (HP:0009699) | 2.78749454 |
| 23 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.78749454 |
| 24 | Generalized aminoaciduria (HP:0002909) | 2.73226236 |
| 25 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.72315449 |
| 26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.72315449 |
| 27 | Abnormality of glycolipid metabolism (HP:0010969) | 2.72315449 |
| 28 | Thyroid carcinoma (HP:0002890) | 2.68649949 |
| 29 | Tubulointerstitial nephritis (HP:0001970) | 2.63631043 |
| 30 | Neoplasm of the small intestine (HP:0100833) | 2.63473765 |
| 31 | Spastic gait (HP:0002064) | 2.63236255 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.60422535 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.60405048 |
| 34 | Hypomagnesemia (HP:0002917) | 2.55866265 |
| 35 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.53381580 |
| 36 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.53381580 |
| 37 | Eczematoid dermatitis (HP:0000976) | 2.52460534 |
| 38 | Prolonged partial thromboplastin time (HP:0003645) | 2.52185106 |
| 39 | Volvulus (HP:0002580) | 2.52164869 |
| 40 | Hypophosphatemic rickets (HP:0004912) | 2.49831168 |
| 41 | Pheochromocytoma (HP:0002666) | 2.49058680 |
| 42 | Autoamputation (HP:0001218) | 2.48857042 |
| 43 | White forelock (HP:0002211) | 2.48279836 |
| 44 | Albinism (HP:0001022) | 2.47218938 |
| 45 | Disinhibition (HP:0000734) | 2.46480378 |
| 46 | Insidious onset (HP:0003587) | 2.45683323 |
| 47 | Termporal pattern (HP:0011008) | 2.45683323 |
| 48 | Rhabdomyosarcoma (HP:0002859) | 2.45291201 |
| 49 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.44135471 |
| 50 | Fat malabsorption (HP:0002630) | 2.43220044 |
| 51 | Onion bulb formation (HP:0003383) | 2.42760870 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 2.40339635 |
| 53 | Hypoplasia of the uterus (HP:0000013) | 2.37632172 |
| 54 | Biliary tract neoplasm (HP:0100574) | 2.36174563 |
| 55 | Ketoacidosis (HP:0001993) | 2.35777146 |
| 56 | Intention tremor (HP:0002080) | 2.35070294 |
| 57 | Cerebral edema (HP:0002181) | 2.34699674 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.32272894 |
| 59 | Abnormality of the common coagulation pathway (HP:0010990) | 2.31929720 |
| 60 | Hyperammonemia (HP:0001987) | 2.31924063 |
| 61 | Neuroendocrine neoplasm (HP:0100634) | 2.26927647 |
| 62 | Thickened helices (HP:0000391) | 2.26822713 |
| 63 | Progressive neurologic deterioration (HP:0002344) | 2.25523306 |
| 64 | Palpitations (HP:0001962) | 2.25045051 |
| 65 | Abnormality of vitamin B metabolism (HP:0004340) | 2.23387739 |
| 66 | Hyperglycemia (HP:0003074) | 2.20313045 |
| 67 | Hyperglycinemia (HP:0002154) | 2.19852779 |
| 68 | Hypsarrhythmia (HP:0002521) | 2.19244077 |
| 69 | Xanthomatosis (HP:0000991) | 2.19119589 |
| 70 | Increased circulating renin level (HP:0000848) | 2.17720978 |
| 71 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.17235776 |
| 72 | Deep venous thrombosis (HP:0002625) | 2.16530609 |
| 73 | EEG with generalized epileptiform discharges (HP:0011198) | 2.15840915 |
| 74 | Akinesia (HP:0002304) | 2.15390816 |
| 75 | Mucosal telangiectasiae (HP:0100579) | 2.15057608 |
| 76 | Constricted visual fields (HP:0001133) | 2.14406125 |
| 77 | Supranuclear gaze palsy (HP:0000605) | 2.14278497 |
| 78 | Epileptiform EEG discharges (HP:0011182) | 2.14179539 |
| 79 | Renal cortical cysts (HP:0000803) | 2.12848580 |
| 80 | Neoplasm of the rectum (HP:0100743) | 2.11233292 |
| 81 | Hypobetalipoproteinemia (HP:0003563) | 2.11226328 |
| 82 | Large for gestational age (HP:0001520) | 2.10269407 |
| 83 | Nausea (HP:0002018) | 2.10121822 |
| 84 | Atonic seizures (HP:0010819) | 2.09450916 |
| 85 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.09027838 |
| 86 | Abnormality of magnesium homeostasis (HP:0004921) | 2.08839804 |
| 87 | Abnormal spermatogenesis (HP:0008669) | 2.08148459 |
| 88 | Epileptic encephalopathy (HP:0200134) | 2.08008121 |
| 89 | Dysostosis multiplex (HP:0000943) | 2.05685205 |
| 90 | Dysmetria (HP:0001310) | 2.05558561 |
| 91 | Periodontitis (HP:0000704) | 2.04860109 |
| 92 | Hypokalemia (HP:0002900) | 2.04218191 |
| 93 | Loss of speech (HP:0002371) | 2.04163104 |
| 94 | Cerebral hemorrhage (HP:0001342) | 2.04122502 |
| 95 | Abnormality of serum amino acid levels (HP:0003112) | 2.04050355 |
| 96 | Peripheral hypomyelination (HP:0007182) | 2.03733575 |
| 97 | Conjunctival telangiectasia (HP:0000524) | 2.03416297 |
| 98 | Abnormality of methionine metabolism (HP:0010901) | 2.01065254 |
| 99 | Poor speech (HP:0002465) | 1.99928255 |
| 100 | Short nail (HP:0001799) | 1.96363385 |
| 101 | Ovarian neoplasm (HP:0100615) | 1.95493289 |
| 102 | Abnormality of macrophages (HP:0004311) | 1.95365411 |
| 103 | Hyperlipoproteinemia (HP:0010980) | 1.95192277 |
| 104 | Retinal dysplasia (HP:0007973) | 1.94536187 |
| 105 | Spastic paraparesis (HP:0002313) | 1.94417273 |
| 106 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94400049 |
| 107 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.93425843 |
| 108 | Gingival bleeding (HP:0000225) | 1.93171713 |
| 109 | Steatorrhea (HP:0002570) | 1.92754694 |
| 110 | Protuberant abdomen (HP:0001538) | 1.91304762 |
| 111 | Conjunctival hamartoma (HP:0100780) | 1.90382159 |
| 112 | Hepatosplenomegaly (HP:0001433) | 1.89764083 |
| 113 | Abnormal biliary tract morphology (HP:0012440) | 1.89436829 |
| 114 | Degeneration of anterior horn cells (HP:0002398) | 1.87824710 |
| 115 | Abnormality of the anterior horn cell (HP:0006802) | 1.87824710 |
| 116 | Increased serum pyruvate (HP:0003542) | 1.87788297 |
| 117 | Increased CSF protein (HP:0002922) | 1.87487656 |
| 118 | Ketosis (HP:0001946) | 1.86916958 |
| 119 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.86491138 |
| 120 | Abnormality of glycine metabolism (HP:0010895) | 1.86491138 |
| 121 | Abnormality of the basal ganglia (HP:0002134) | 1.86332615 |
| 122 | Hypokalemic alkalosis (HP:0001949) | 1.85590089 |
| 123 | Medulloblastoma (HP:0002885) | 1.85090454 |
| 124 | Abnormal drinking behavior (HP:0030082) | 1.85069386 |
| 125 | Polydipsia (HP:0001959) | 1.85069386 |
| 126 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.84685519 |
| 127 | Petechiae (HP:0000967) | 1.83956858 |
| 128 | Hyperphosphatemia (HP:0002905) | 1.83732272 |
| 129 | Focal motor seizures (HP:0011153) | 1.83395337 |
| 130 | Anteriorly placed anus (HP:0001545) | 1.83376115 |
| 131 | Hyperventilation (HP:0002883) | 1.83183487 |
| 132 | Slow saccadic eye movements (HP:0000514) | 1.83131316 |
| 133 | Clumsiness (HP:0002312) | 1.82601480 |
| 134 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.82146565 |
| 135 | Abnormality of potassium homeostasis (HP:0011042) | 1.80055358 |
| 136 | Acute hepatic failure (HP:0006554) | 1.79876294 |
| 137 | Abnormality of urine glucose concentration (HP:0011016) | 1.79808768 |
| 138 | Glycosuria (HP:0003076) | 1.79808768 |
| 139 | Cone-rod dystrophy (HP:0000548) | 1.79151695 |
| 140 | Abnormality of chromosome stability (HP:0003220) | 1.78895972 |
| 141 | Azoospermia (HP:0000027) | 1.78104858 |
| 142 | Papillary thyroid carcinoma (HP:0002895) | 1.77758732 |
| 143 | Generalized myoclonic seizures (HP:0002123) | 1.77663643 |
| 144 | Lower limb hyperreflexia (HP:0002395) | 1.77466096 |
| 145 | Hypothermia (HP:0002045) | 1.77370953 |
| 146 | Type II lissencephaly (HP:0007260) | 1.76341768 |
| 147 | Acute encephalopathy (HP:0006846) | 1.75920061 |
| 148 | Sensorimotor neuropathy (HP:0007141) | 1.75913881 |
| 149 | Erythroderma (HP:0001019) | 1.75157361 |
| 150 | Choroideremia (HP:0001139) | 1.74501265 |
| 151 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.73109620 |
| 152 | Metabolic acidosis (HP:0001942) | 1.72441330 |
| 153 | Infantile muscular hypotonia (HP:0008947) | 1.71987534 |
| 154 | Pancreatitis (HP:0001733) | 1.71894561 |
| 155 | Megaloblastic anemia (HP:0001889) | 1.71126256 |
| 156 | Spastic tetraparesis (HP:0001285) | 1.68420519 |
| 157 | Clonus (HP:0002169) | 1.68149518 |
| 158 | Megalencephaly (HP:0001355) | 1.66953914 |
| 159 | Cutaneous melanoma (HP:0012056) | 1.65979151 |
| 160 | Hypolipoproteinemia (HP:0010981) | 1.65784473 |
| 161 | Recurrent skin infections (HP:0001581) | 1.65542462 |
| 162 | Orthostatic hypotension (HP:0001278) | 1.65424800 |
| 163 | Increased cerebral lipofuscin (HP:0011813) | 1.65037912 |
| 164 | Abnormality of vitamin metabolism (HP:0100508) | 1.64701102 |
| 165 | Lethargy (HP:0001254) | 1.64255689 |
| 166 | Exocrine pancreatic insufficiency (HP:0001738) | 1.64152268 |
| 167 | Postural tremor (HP:0002174) | 1.64109548 |
| 168 | Choreoathetosis (HP:0001266) | 1.63899350 |
| 169 | Metaphyseal irregularity (HP:0003025) | 1.63154473 |
| 170 | Vacuolated lymphocytes (HP:0001922) | 1.62526448 |
| 171 | Hyperglycinuria (HP:0003108) | 1.62229361 |
| 172 | Stridor (HP:0010307) | 1.61533802 |
| 173 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.60946952 |
| 174 | Abnormal gallbladder morphology (HP:0012437) | 1.60677248 |
| 175 | Progressive macrocephaly (HP:0004481) | 1.58808485 |
| 176 | Osteomyelitis (HP:0002754) | 1.58180621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.26747767 |
| 2 | INSRR | 3.54354159 |
| 3 | OXSR1 | 3.41486262 |
| 4 | NEK9 | 3.02456379 |
| 5 | ERBB3 | 2.97336080 |
| 6 | MAP3K12 | 2.88133811 |
| 7 | ACVR1B | 2.79514338 |
| 8 | BCR | 2.77101159 |
| 9 | BCKDK | 2.72877310 |
| 10 | WNK4 | 2.70871259 |
| 11 | FRK | 2.33502474 |
| 12 | STK24 | 2.24788227 |
| 13 | ERBB4 | 2.20150922 |
| 14 | EPHB1 | 2.19508004 |
| 15 | PRPF4B | 2.06047371 |
| 16 | EIF2AK1 | 2.04301778 |
| 17 | STK38L | 1.95124943 |
| 18 | CASK | 1.94710595 |
| 19 | MET | 1.92452814 |
| 20 | TAOK3 | 1.91033194 |
| 21 | MAP3K2 | 1.85447818 |
| 22 | MAP3K13 | 1.84883231 |
| 23 | TYK2 | 1.75233100 |
| 24 | WNK1 | 1.69610476 |
| 25 | STK3 | 1.68698005 |
| 26 | NTRK1 | 1.67554609 |
| 27 | MAPK15 | 1.64895829 |
| 28 | NEK1 | 1.59293007 |
| 29 | SGK494 | 1.58531622 |
| 30 | SGK223 | 1.58531622 |
| 31 | PKN1 | 1.57656805 |
| 32 | CDK19 | 1.56300485 |
| 33 | PDK2 | 1.54067972 |
| 34 | FGFR2 | 1.53846086 |
| 35 | CCNB1 | 1.48659519 |
| 36 | BRSK2 | 1.47889859 |
| 37 | NEK6 | 1.46448244 |
| 38 | YES1 | 1.44051774 |
| 39 | PAK3 | 1.41311363 |
| 40 | TSSK6 | 1.37164318 |
| 41 | MST4 | 1.36847981 |
| 42 | CSNK1A1L | 1.36837230 |
| 43 | BMPR2 | 1.27856510 |
| 44 | TRIM28 | 1.26551545 |
| 45 | AKT3 | 1.25401800 |
| 46 | MAP4K2 | 1.23090264 |
| 47 | NTRK3 | 1.21246708 |
| 48 | ADRBK2 | 1.20335519 |
| 49 | TNIK | 1.18862575 |
| 50 | CAMK2B | 1.18083348 |
| 51 | MAPKAPK5 | 1.17888738 |
| 52 | SCYL2 | 1.16142689 |
| 53 | TAF1 | 1.16123641 |
| 54 | BMPR1B | 1.15934532 |
| 55 | MYLK | 1.14792011 |
| 56 | IRAK2 | 1.12866005 |
| 57 | CSNK1G3 | 1.12274793 |
| 58 | MAP3K14 | 1.12051530 |
| 59 | ARAF | 1.11441825 |
| 60 | BRAF | 1.11316102 |
| 61 | UHMK1 | 1.09310843 |
| 62 | NUAK1 | 1.08483146 |
| 63 | KSR2 | 1.06515287 |
| 64 | TTK | 1.04683196 |
| 65 | MAP3K4 | 1.04563166 |
| 66 | HIPK2 | 1.01814499 |
| 67 | PBK | 1.01414214 |
| 68 | EIF2AK2 | 0.99870258 |
| 69 | PRKCQ | 0.99467033 |
| 70 | CSNK1G2 | 0.98595966 |
| 71 | IRAK1 | 0.98249658 |
| 72 | CAMK2D | 0.94762213 |
| 73 | BLK | 0.94388950 |
| 74 | ITK | 0.93760660 |
| 75 | MAP2K3 | 0.93057448 |
| 76 | FGR | 0.91349138 |
| 77 | MST1R | 0.90214942 |
| 78 | CDK5 | 0.90065922 |
| 79 | TGFBR2 | 0.89876709 |
| 80 | PINK1 | 0.89861039 |
| 81 | STK10 | 0.89614816 |
| 82 | CSNK1G1 | 0.89309448 |
| 83 | PRKCE | 0.88764045 |
| 84 | RPS6KA4 | 0.87501351 |
| 85 | PAK6 | 0.86334628 |
| 86 | LIMK1 | 0.85822460 |
| 87 | JAK1 | 0.85458080 |
| 88 | STK4 | 0.84507548 |
| 89 | PNCK | 0.83797168 |
| 90 | CAMK2A | 0.83176821 |
| 91 | PDPK1 | 0.82620783 |
| 92 | PRKG2 | 0.82409945 |
| 93 | WNK3 | 0.81943659 |
| 94 | EPHA4 | 0.81541390 |
| 95 | LMTK2 | 0.81235122 |
| 96 | ROCK2 | 0.79884716 |
| 97 | CSF1R | 0.78032609 |
| 98 | PIK3CG | 0.77982082 |
| 99 | PRKCH | 0.77454935 |
| 100 | PLK3 | 0.75237812 |
| 101 | SGK2 | 0.73209191 |
| 102 | CAMKK2 | 0.72314123 |
| 103 | PLK4 | 0.70083464 |
| 104 | CDK6 | 0.69580438 |
| 105 | ICK | 0.67381501 |
| 106 | CAMK2G | 0.66405904 |
| 107 | TEC | 0.65018681 |
| 108 | GRK7 | 0.64970839 |
| 109 | DMPK | 0.64628775 |
| 110 | MELK | 0.64366387 |
| 111 | RIPK4 | 0.63466187 |
| 112 | MAP2K7 | 0.62438067 |
| 113 | NLK | 0.61786269 |
| 114 | RET | 0.59930536 |
| 115 | VRK1 | 0.59347926 |
| 116 | PDK1 | 0.59001704 |
| 117 | LRRK2 | 0.57097333 |
| 118 | MAP3K1 | 0.55849461 |
| 119 | TGFBR1 | 0.55774953 |
| 120 | CDK14 | 0.55758282 |
| 121 | STK16 | 0.55384962 |
| 122 | KSR1 | 0.55141482 |
| 123 | FGFR3 | 0.54234001 |
| 124 | BUB1 | 0.54114110 |
| 125 | DYRK3 | 0.54097138 |
| 126 | PASK | 0.53408407 |
| 127 | SGK1 | 0.53199901 |
| 128 | PTK2 | 0.52900752 |
| 129 | MOS | 0.52269544 |
| 130 | PRKG1 | 0.52007865 |
| 131 | MKNK1 | 0.51460137 |
| 132 | NME2 | 0.50422849 |
| 133 | MAP3K9 | 0.50096476 |
| 134 | MARK2 | 0.49234384 |
| 135 | ABL1 | 0.48870652 |
| 136 | PLK2 | 0.48866803 |
| 137 | GRK1 | 0.48347845 |
| 138 | WEE1 | 0.46110291 |
| 139 | FER | 0.44827034 |
| 140 | PRKD1 | 0.44826937 |
| 141 | TRPM7 | 0.44777310 |
| 142 | EGFR | 0.43955282 |
| 143 | EPHA3 | 0.43831083 |
| 144 | TXK | 0.43269442 |
| 145 | MATK | 0.42115338 |
| 146 | EIF2AK3 | 0.41909852 |
| 147 | HCK | 0.41714332 |
| 148 | RAF1 | 0.41524955 |
| 149 | CSNK1A1 | 0.40715031 |
| 150 | MAP2K4 | 0.40516793 |
| 151 | CSK | 0.39366617 |
| 152 | GSK3A | 0.39214066 |
| 153 | JAK2 | 0.38964015 |
| 154 | PAK4 | 0.37440557 |
| 155 | IKBKB | 0.36730638 |
| 156 | INSR | 0.36596072 |
| 157 | GRK5 | 0.36452679 |
| 158 | FYN | 0.36164971 |
| 159 | ATM | 0.35794046 |
| 160 | CDK18 | 0.35753316 |
| 161 | SGK3 | 0.34741926 |
| 162 | MAP3K8 | 0.34669902 |
| 163 | PRKAA2 | 0.31552476 |
| 164 | CDK8 | 0.31470330 |
| 165 | ZAK | 0.30026687 |
| 166 | LYN | 0.29587431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.69576076 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.45235245 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.36838738 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.18015172 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.10480385 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.83985070 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.70501622 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.39354093 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.09991293 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.03838473 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.02094391 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98603810 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70645489 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.69193936 |
| 15 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.65439030 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63970210 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.63580409 |
| 18 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61733292 |
| 19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.54513392 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.51251020 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47366025 |
| 22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.44821490 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.39312692 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.37866274 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.34562477 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.34027384 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.29538631 |
| 28 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.27059007 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25570375 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24964720 |
| 31 | Proteasome_Homo sapiens_hsa03050 | 1.21474316 |
| 32 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.20230237 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.19283300 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15738315 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.13641595 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.13063493 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.13013241 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.12002606 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.10784196 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10419664 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 1.05986728 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04726620 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01629526 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01384891 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99398689 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.99186418 |
| 47 | Cocaine addiction_Homo sapiens_hsa05030 | 0.97932731 |
| 48 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97886328 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.96853339 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 0.92168625 |
| 51 | Leishmaniasis_Homo sapiens_hsa05140 | 0.91855232 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90607633 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90027318 |
| 54 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.89317258 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.89273374 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.88455483 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.87853286 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87619288 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86957007 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86731539 |
| 61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.86345265 |
| 62 | Axon guidance_Homo sapiens_hsa04360 | 0.86042660 |
| 63 | Morphine addiction_Homo sapiens_hsa05032 | 0.84507416 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83380857 |
| 65 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82394576 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.82072396 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80947053 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80839859 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.80038283 |
| 70 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79896877 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79741724 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79506737 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78589034 |
| 74 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.78148793 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.77942575 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76920929 |
| 77 | Long-term depression_Homo sapiens_hsa04730 | 0.76595861 |
| 78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73622857 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.73577496 |
| 80 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.73501628 |
| 81 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72293276 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72277051 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70456749 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69468130 |
| 85 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.67979094 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67141465 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66001319 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65941413 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.65014533 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64957696 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63892913 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63532194 |
| 93 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62908866 |
| 94 | Measles_Homo sapiens_hsa05162 | 0.60940037 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60731495 |
| 96 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59858722 |
| 97 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.59496695 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59326671 |
| 99 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.56811067 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56132219 |
| 101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56113766 |
| 102 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56015640 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55949007 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52915650 |
| 105 | Taste transduction_Homo sapiens_hsa04742 | 0.52605031 |
| 106 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52181863 |
| 107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51779476 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51727154 |
| 109 | Tuberculosis_Homo sapiens_hsa05152 | 0.51664932 |
| 110 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.50929772 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50903155 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50337322 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49717923 |
| 114 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49626848 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48675893 |
| 116 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48352102 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48283530 |
| 118 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47829490 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47517525 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47436528 |
| 121 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.46958054 |
| 122 | Malaria_Homo sapiens_hsa05144 | 0.46195641 |
| 123 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46139194 |
| 124 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45826299 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.45714190 |
| 126 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44178603 |
| 127 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44138675 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43924638 |
| 129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43459486 |
| 130 | Homologous recombination_Homo sapiens_hsa03440 | 0.43264821 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40948579 |
| 132 | DNA replication_Homo sapiens_hsa03030 | 0.40154919 |
| 133 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40046087 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39591054 |
| 135 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38406246 |
| 136 | Base excision repair_Homo sapiens_hsa03410 | 0.37865014 |
| 137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37143107 |
| 138 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37066892 |
| 139 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36485162 |
| 140 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36330811 |
| 141 | Parkinsons disease_Homo sapiens_hsa05012 | 0.36162837 |
| 142 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36007512 |
| 143 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34999200 |
| 144 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33645072 |
| 145 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33549844 |
| 146 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33278672 |
| 147 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33091579 |
| 148 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31934103 |
| 149 | Endocytosis_Homo sapiens_hsa04144 | 0.31848428 |
| 150 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31398677 |
| 151 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30848857 |

